Brian G. Drazba Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian G. Drazba.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian G. Drazba. Brian G. Drazba is VP, Finance & CFO in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and VP, Finance & CAO in ISTA PHARMACEUTICALS INC ($ISTA) and Chief Financial Officer in MEI Pharma, Inc. ($MEIP).
Latest Insider Trading Transactions of Brian G. Drazba
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HRTX, ISTA, MEIP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 3.49 | 230,000 | 802,700 | 230,000 | |
| Dec 20 2019 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Buy | P | 1.60 | 12,500 | 20,000 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jul 03 2019 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 2.52 | 230,000 | 579,600 | 230,000 | |
| Jul 16 2018 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
| Jun 26 2018 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 4.33 | 130,000 | 562,900 | 130,000 | |
| Jul 10 2017 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 2.83 | 50,000 | 141,500 | 200,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 12.62 | 538 | 6,791 | 3,798 | 3.3 K to 3.8 K (+16.50 %) |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 18.22 | 577 | 10,515 | 3,260 | 2.7 K to 3.3 K (+21.51 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Option Exercise | A | 29.41 | 50,000 | 1,470,500 | 50,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 9.36 | 714 | 6,682 | 2,683 | 2 K to 2.7 K (+36.26 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 7.60 | 1,151 | 8,746 | 1,969 | 818 to 2 K (+140.71 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | M | 4.58 | 4,250 | 19,465 | 584 | |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | M | 4.58 | 2,416 | 11,065 | 4,834 | |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | M | 3.71 | 19,125 | 70,954 | 7,875 | |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | M | 3.63 | 7,492 | 27,196 | 5,828 | |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Payment of Exercise | F | 9.08 | 2,144 | 19,468 | 40,487 | 42.6 K to 40.5 K (-5.03 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Buy | M | 4.58 | 4,250 | 19,465 | 42,631 | 38.4 K to 42.6 K (+11.07 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Payment of Exercise | F | 9.08 | 1,219 | 11,069 | 38,381 | 39.6 K to 38.4 K (-3.08 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Buy | M | 4.58 | 2,416 | 11,065 | 39,600 | 37.2 K to 39.6 K (+6.50 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Payment of Exercise | F | 9.08 | 2,995 | 27,195 | 37,184 | 40.2 K to 37.2 K (-7.45 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Buy | M | 3.63 | 7,492 | 27,196 | 40,179 | 32.7 K to 40.2 K (+22.92 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Payment of Exercise | F | 9.08 | 7,814 | 70,951 | 32,687 | 40.5 K to 32.7 K (-19.29 %) |
| May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Buy | M | 3.71 | 19,125 | 70,954 | 40,501 | 21.4 K to 40.5 K (+89.47 %) |
| Dec 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 3.75 | 1,940 | 7,275 | 1,940 | |
| Dec 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 3.75 | 29,935 | 112,256 | 29,935 | |
| Dec 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Grant | A | 0.00 | 8,083 | 8 | 21,376 | 13.3 K to 21.4 K (+60.81 %) |
| Aug 12 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Buy | P | 4.38 | 1,500 | 6,567 | 13,293 | 11.8 K to 13.3 K (+12.72 %) |
| Feb 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Grant | A | 0.00 | 2,833 | 3 | 11,793 | 9 K to 11.8 K (+31.62 %) |
| Dec 20 2010 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 4.58 | 7,250 | 33,205 | 7,250 | |
| Dec 20 2010 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 4.58 | 12,750 | 58,395 | 12,750 |
Page: 1